ICON Launches New Functional Service Provision (FSP) Strategy

ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a new functional resourcing strategy delivered by a dedicated division, DOCS.

DOCS has been a leading provider of resourcing services to the global biopharmaceutical and medical device industry for over 15 years. To meet the growing demand for FSP solutions, DOCS has developed the FSP Delivery Platform™. This combines DOCS’ global resourcing engine with the processes, quality oversight, systems, and training and governance structures to drive productivity through flexible FSP models. The DOCS FSP Delivery Platform™ also leverages ICON’s extensive therapeutic, geographic and functional expertise to ensure greater efficiencies across customer programs.

“Functional resourcing and FSP continue to grow in popularity as sponsors look for innovative outsourcing strategies that enable them to gain efficiencies and accelerate the development of their pipelines,” commented Colin Stanley, President, DOCS. “DOCS’ core competency is providing highly talented teams with skills and experience that are aligned with the needs of our clients and which seamlessly integrate with their business. Our new FSP Delivery Platform builds on this competency and also allows clients to benefit from the breadth and depth of capabilities and expertise from the wider ICON organisation.”

The DOCS FSP business will be led by Barry Balfe, Vice President Global Program Management. Barry has 12 years of clinical research experience and has held leadership positions in both operations and business development for DOCS.

About DOCS

DOCS, a division of ICON plc, is a leading provider of global resourcing solutions to the pharmaceutical, biotechnology and medical device industries. The company specialises in four core service areas: Functional Service Provision, Contract Placement, Permanent Placement and Executive Search. DOCS has a global resourcing network and operational infrastructure across 82 locations in 40 countries enabling access to an extensive global pool of candidates. Further information is available at www.docsglobal.com

Copyright Business Wire 2010

If you liked this article you might like

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

Icon (ICLR) Marked As A Barbarian At The Gate

Icon (ICLR) Marked As A Barbarian At The Gate

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

Goldman Sachs Gives These 4 Cheap Stocks a Thumbs Up and So Do the Charts

Goldman Sachs Gives These 4 Cheap Stocks a Thumbs Up and So Do the Charts

14 Cheap Stocks to Buy Now From Goldman Sachs

14 Cheap Stocks to Buy Now From Goldman Sachs